| |
|
|
|
Evelo Biosciences Inc  
|
|
16.66 0.95 (0.06%) |
01-25 16:00 |
|
Open: |
16.04 |
Pre close: |
15.71 |
Target:
|
20.63
|
|
High: |
16.76 |
Low: |
14.765 |
Resistance:
|
17.66
20.63
|
|
Volume: |
239,972 |
Market Cap: |
770M |
Support:
|
12.01
8.52
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
15.39
 |
MACD |
MACD(12,26):
|
1.78 |
|
MA(20): |
13.24 |
Signal(12,26,9): |
1.68 |
|
MA(100): |
7.01 |
Stochastic Oscillator |
%K(14,3):
|
66.77 |
|
MA(250): |
5.52 |
%D(3): |
64.72  |
|
Average Volume(K) |
3-Month: |
35533
|
52-Week |
High:
|
17.66 |
|
10-Days: |
22590 |
Low: |
3.01 |
|
RSI |
RSI(14):
|
71.58 |
Change(%): |
136.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.430 |
Return on Equity (ttm) |
-133.2 |
Shares Out. (M) |
46.19 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-50.0 |
Shares Float (M) |
19.99 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.52 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
87.46 |
|
Forward EPS |
-2.780 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
2000 |
|
Book Value (p.s.) |
1.090 |
EBITDA (p.s.) |
-1.826 |
P/E |
-6.86 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
15.28 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-73.10 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-42.98 |
P/CF |
-10.53 |
|
|
|
|
|
|
